Osaic Holdings’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $41.8K | Buy |
1,244
+1,053
| +551% | +$35.4K | ﹤0.01% | 4836 |
|
2025
Q1 | $6.41K | Sell |
191
-272
| -59% | -$9.13K | ﹤0.01% | 5962 |
|
2024
Q4 | $18.1K | Buy |
463
+4
| +0.9% | +$157 | ﹤0.01% | 5379 |
|
2024
Q3 | $18.1K | Sell |
459
-78
| -15% | -$3.07K | ﹤0.01% | 5397 |
|
2024
Q2 | $20.9K | Sell |
537
-293
| -35% | -$11.4K | ﹤0.01% | 5274 |
|
2024
Q1 | $35.7K | Sell |
830
-1,835
| -69% | -$79K | ﹤0.01% | 4952 |
|
2023
Q4 | $123K | Sell |
2,665
-1,222
| -31% | -$56.3K | ﹤0.01% | 4278 |
|
2023
Q3 | $133K | Buy |
3,887
+1,196
| +44% | +$40.8K | ﹤0.01% | 4293 |
|
2023
Q2 | $104K | Buy |
2,691
+2,009
| +295% | +$77.3K | ﹤0.01% | 4409 |
|
2023
Q1 | $24.4K | Buy |
682
+6
| +0.9% | +$215 | ﹤0.01% | 5437 |
|
2022
Q4 | $27K | Buy |
676
+85
| +14% | +$3.4K | ﹤0.01% | 5359 |
|
2022
Q3 | $22K | Buy |
591
+328
| +125% | +$12.2K | ﹤0.01% | 5512 |
|
2022
Q2 | $8K | Buy |
263
+163
| +163% | +$4.96K | ﹤0.01% | 6230 |
|
2022
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 6650 |
|
2021
Q4 | $3K | Sell |
100
-275
| -73% | -$8.25K | ﹤0.01% | 6788 |
|
2021
Q3 | $6K | Hold |
375
| – | – | ﹤0.01% | 6451 |
|
2021
Q2 | $7K | Sell |
375
-375
| -50% | -$7K | ﹤0.01% | 6233 |
|
2021
Q1 | $13K | Hold |
750
| – | – | ﹤0.01% | 5717 |
|
2020
Q4 | $12K | Hold |
750
| – | – | ﹤0.01% | 5405 |
|
2020
Q3 | $8K | Hold |
750
| – | – | ﹤0.01% | 5367 |
|
2020
Q2 | $9K | Hold |
750
| – | – | ﹤0.01% | 5200 |
|
2020
Q1 | $9K | Buy |
+750
| New | +$9K | ﹤0.01% | 5033 |
|